Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$212.38 - $245.9 $63 Million - $73 Million
-296,814 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$212.5 - $245.46 $2.69 Million - $3.11 Million
12,661 Added 4.46%
296,814 $65.9 Million
Q3 2020

Nov 09, 2020

SELL
$177.16 - $215.33 $3.42 Million - $4.16 Million
-19,307 Reduced 6.36%
284,153 $61.2 Million
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $2.09 Million - $2.88 Million
16,265 Added 5.66%
303,460 $53.7 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $2.7 Million - $3.76 Million
-22,242 Reduced 7.19%
287,195 $39.8 Million
Q4 2019

Feb 13, 2020

BUY
$133.47 - $153.48 $3.58 Million - $4.12 Million
26,819 Added 9.49%
309,437 $47.5 Million
Q3 2019

Nov 12, 2019

BUY
$135.4 - $146.47 $1.29 Million - $1.4 Million
9,526 Added 3.49%
282,618 $40.8 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $244,889 - $281,854
1,961 Added 0.72%
273,092 $39 Million
Q1 2019

May 15, 2019

SELL
$97.62 - $132.29 $2.92 Million - $3.95 Million
-29,870 Reduced 9.92%
271,131 $35.8 Million
Q4 2018

Feb 13, 2019

SELL
$94.85 - $109.54 $1.54 Million - $1.77 Million
-16,199 Reduced 5.11%
301,001 $31 Million
Q3 2018

Nov 13, 2018

SELL
$98.13 - $108.9 $254,254 - $282,159
-2,591 Reduced 0.81%
317,200 $34.5 Million
Q2 2018

Aug 13, 2018

SELL
$96.1 - $103.24 $881,333 - $946,814
-9,171 Reduced 2.79%
319,791 $31.6 Million
Q1 2018

May 15, 2018

SELL
$92.16 - $103.8 $1.65 Million - $1.85 Million
-17,869 Reduced 5.15%
328,962 $32.2 Million
Q4 2017

Feb 07, 2018

SELL
$85.26 - $94.62 $797,351 - $884,886
-9,352 Reduced 2.63%
346,831 $32.2 Million
Q3 2017

Nov 06, 2017

BUY
$79.29 - $88.45 $28.2 Million - $31.5 Million
356,183
356,183 $30.6 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Bristol Gate Capital Partners Inc. Portfolio

Follow Bristol Gate Capital Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristol Gate Capital Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bristol Gate Capital Partners Inc. with notifications on news.